EveryWare Global, Inc. (NASDAQ:EVRY) said in a regulatory filing on Thursday that it had struck an agreement to sell the business for an estimated $6.14 million to HUK 54 Ltd. HUK is a subsidiary of U.K.-based Hilco Capital Ltd., which specializes in turning around distressed retail companies. The sale only includes EveryWare’s business in the United Kingdom and does not include the rights to license the Oneida, Anchor Hocking or Sant’ Andrea brands. “This transaction represents another step toward building a profitable future for EveryWare,” CEO Sam Solomon said in a statement. EveryWare Global, Inc. (NASDAQ:EVRY) belongs to Consumer Goods sector. Its net profit margin is -12.80% and weekly performance is 45.02%. On last trading day company shares ended up $3.35. EveryWare Global, Inc. (NASDAQ:EVRY) distance from 50-day simple moving average (SMA50) is 44.82%.
Enzon Pharmaceuticals Inc. (NASDAQ:ENZN)’s stock was upgraded by investment analysts at TheStreet from a “sell” rating to a “hold” rating in a note issued to investors on July 8. The analysts wrote, “Enzon Pharmaceuticals (ENZN) has been upgraded by TheStreet Ratings from sell to hold. The company’s strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, notable return on equity and attractive valuation levels. However, as a counter to these strengths, we find that revenues have generally been declining.” Enzon Pharmaceuticals Inc. (NASDAQ:ENZN) shares fell -4.73% in last trading session and ended the day at $1.61. ENZN return on assets is 158.00%. Enzon Pharmaceuticals Inc. (NASDAQ:ENZN) quarterly performance is 78.89%.
Concur Technologies Inc. (NASDAQ:CNQR) CFO Francis J. Pelzer sold 2,000 shares of the company’s stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $110.01, for a total transaction of $220,020.00. Following the transaction, the chief financial officer now directly owns 36,479 shares of the company’s stock, valued at approximately $4,013,055. On 05 September, Concur Technologies, Inc. (NASDAQ:CNQR) shares increased 2.43% and was closed at $108.76. CNQR EPS growth in last 5 year was -26.60%. Concur Technologies, Inc. (NASDAQ:CNQR) year to date (YTD) performance is 5.41%.
Nova Measuring Instruments (NASDAQ:NVMI), a leading innovator and a key provider of optical metrology solutions for advanced process control used in semiconductor manufacturing, today reported 2014 second quarter results. Quarterly revenues of $32.8 million, up 17% from $28.1 million a year ago. Revenue for the six months ended June 30, 2014 of $67.5 million, up 21% from $55.5 million in the same period a year ago. Quarterly gross margin of 54%, compared with 55% a year ago. Quarterly net income of $5.7 million, up 103% from $2.8 million a year ago. Net income for the six months ended June 30, 2014 of $12.1 million, up 133% from $5.2 million in the same period a year ago. Total cash reserves of $114.1 million as of June 30, 2014, and no debt. Initiated previously-announced $12 million share repurchase program. Nova Measuring Instruments Ltd. (NASDAQ:NVMI) ended the last trading day at $11.14. Company weekly volatility is calculated as 1.41%and price to cash ratio as 2.77. Nova Measuring Instruments Ltd. (NASDAQ:NVMI) showed a weekly performance of 0.00%.
Certain BlackRock closed-end funds (the “Funds”) announced distributions. BlackRock EcoSolutions Investment Trust (BQR) announced a distribution reduction. BQR’s distribution reduction reflects the current level of the Fund’s net assets and current and projected levels of dividend income, option premiums and volatility in the market. BlackRock Maryland Municipal Bond Trust (NYSEMKT:BZM) shares increased 0.59% in last trading session and ended the day on $14.80. BlackRock Maryland Municipal Bond Trust (NYSEMKT:BZM) quarterly performance is 8.17%.